Overview
Scleroderma is a rare, autoimmune, chronic, connective tissue disease with vascular damage,
immune system activation and extensive fibrosis.
It has an idiopathic cause and not contagious.
No drug has been clearly proven that would stop or reverse the skin thickening and tightening manifestation of scleroderma. Pharmacotherapy is primarily for symptomatic treatment and prevention of complications of scleroderma.
For further information regarding the management of Scleroderma, please refer to Disease Algorithm for the Treatment Guideline.
It has an idiopathic cause and not contagious.
No drug has been clearly proven that would stop or reverse the skin thickening and tightening manifestation of scleroderma. Pharmacotherapy is primarily for symptomatic treatment and prevention of complications of scleroderma.
For further information regarding the management of Scleroderma, please refer to Disease Algorithm for the Treatment Guideline.
